| EPA0057 | Mauritian cynomolgus macaques are a unique model of post-treatment control of SIV replication | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0056 | HIV proviral reactivation is impaired in effector memory CD4+ T cells by immunometabolic reprogramming with dasatinib | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0055 | Developing an ultrasensitive assay to quantify HIV-1 envelope protein in different matrixes | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0054 | P400/Tip60 chromatin remodeling complex in HIV transcription and latency establishment | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0053 | Identification of novel PTPN1/PTPN2 inhibitors to target latent HIV reservoirs | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0052 | Costimulation with MAdCAM and retinoic acid generates the formation of gut tissue resident memory CD8 T cells that express E-cadherin | E-poster | Host immune responses, vaccines and immunotherapies |
| EPA0051 | Specific immunological response after administration of anti-meningococcal quadrivalent conjugate vaccine MENVEO® in a population of vertically HIV-infected children, adolescents and young adults | E-poster | Host immune responses, vaccines and immunotherapies |
| EPA0050 | Post-treatment controllers exhibit distinct CD8+ T cell features before and after ART interruption | E-poster | Host immune responses, vaccines and immunotherapies |
| EPA0049 | HIV vaccine candidate efficacy mediated by epigenetic changes in CD14+ cells and cAMP-dependent efferocytosis | E-poster | Host immune responses, vaccines and immunotherapies |
| EPA0048 | Feasibility of iNKT cells as an immunotherapeutic HIV cure intervention | E-poster | Host immune responses, vaccines and immunotherapies |